When it comes to product development, the management of third-party intellectual property (IP) to ensure freedom to operate is of paramount importance. Drug development is no different. Imagine ...
Roche Holding AG was barred by an appeals court on Friday from selling the anemia drug Mircera in the United States, after a judge found that the company infringes Amgen Inc.’s patents. The U.S. Court ...
Credit: Getty Images. Vadadustat is an oral hypoxia-inducible factor prolyl hydroxylase inhibitor. Vadadustat was found to be noninferior to a long-acting erythropoiesis-stimulating agent (ESA) for ...
Amgen Inc. said late Tuesday that a U.S. district court issued a final injunction that bars Swiss drug maker Roche Group from selling its anemia drug Mircera in the United States until 2014. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results